13.06.2014 • NewsDede WillamsOxea

Oxea Puts US Intermediates Customers on Allocation

The intermediates business of US-based Oxea Corporation has put all customers on allocation, due to technical issues arising from a scheduled maintenance turn-around at its Bay City, Texas, facility.  

All units are now up and running, although inventories of oxo and esters are extremely low throughout the supply chain, the company said.

Oxea said customers will be supplied based on their average monthly consumption over the past 6 months or as contracts allow.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Digital Validation
Transforming from Paper to Digital

Digital Validation

Our experts will delve into the recently released International Society for Pharmaceutical Engineering (ISPE) Good Practice Guide: Digital Validation